Relationship between Apparent Diffusion Coefficient Distribution and Cancer Grade in Prostate Cancer and Benign Prostatic Hyperplasia

被引:9
作者
Saito, Shigeyoshi [1 ,2 ]
Koyama, Yoshihiro [3 ]
Ueda, Junpei [1 ]
Hashido, Takashi [3 ]
机构
[1] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Med Phys & Engn, Osaka 5650871, Japan
[2] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Adv Med Technol, Osaka 5650871, Japan
[3] Osaka Univ Hosp, Dept Med Technol, Div Radiol, Osaka 5648565, Japan
基金
日本学术振兴会;
关键词
histogram-derived ADC parameters; stromal hyperplasia; glandular hyperplasia; prostate cancer; benign prostate hyperplasia; CONTRAST-ENHANCED MRI; LOCAL TREATMENT; GLEASON SCORE; NORMAL TISSUE; GUIDELINES; DIAGNOSIS; DIFFERENTIATION; CELLULARITY; UPDATE; BIOPSY;
D O I
10.3390/diagnostics12020525
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this paper was to assess the associations between prostate cancer aggressiveness and histogram-derived apparent diffusion coefficient (ADC) parameters and determine which ADC parameters may help distinguish among stromal hyperplasia (SH), glandular hyperplasia (GH), and low-grade, intermediate-grade, and high-grade prostate cancers. The mean, median, minimum, maximum, and 10th and 25th percentile ADC values were determined from the ADC histogram and compared among two benign prostate hyperplasia (BPH) groups and three Gleason score (GS) groups. Seventy lesions were identified in 58 patients who had undergone proctectomy. Thirty-nine lesions were prostate cancers (GS 6 = 7 lesions, GS 7 = 19 lesions, GS 8 = 11 lesions, GS 9 = 2 lesions), and thirty-one lesions were BPH (SH = 15 lesions, GH = 16 lesions). There were statistically significant differences in 10th percentile and 25th percentile ADC values when comparing GS 6 to GS 7 (p < 0.05). The 10th percentile ADC values yielded the highest area under the curve (AUC). Tenth and 25th percentile ADCs can be used to more accurately differentiate lesions with GS 6 from those with GS 7 than other ADC parameters. Our data indicate that the major challenge with ADC mapping is to differentiate between SH and GS 6, and SH and GS 7.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Statin's role on protection from the benign prostatic hyperplasia and prostate cancer
    Hasirci, Eray
    Oguzulgen, Ibrahim
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2012, 11 (04): : 270 - 274
  • [32] Differentiation of prostate cancer and stromal hyperplasia in the transition zone with histogram analysis of the apparent diffusion coefficient
    Liu Xiaohang
    Zhou Bingni
    Zhou Liangping
    Peng Weijun
    Yang Xiaoqun
    Zhang Yong
    ACTA RADIOLOGICA, 2017, 58 (12) : 1528 - 1534
  • [33] Interactions between benign prostatic hyperplasia (BPH) and prostate cancer in large prostates: a retrospective data review
    Al-Khalil, Shadi
    Boothe, David
    Durdin, Trey
    Sunkara, Sowmya
    Watkins, Phillip
    Yang, Shengping
    Haynes, Allan
    de Riese, Werner
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (01) : 91 - 97
  • [34] In Vivo Quantification of Water Diffusion, Stiffness, and Tissue Fluidity in Benign Prostatic Hyperplasia and Prostate Cancer
    Asbach, Patrick
    Ro, Sa-Ra
    Aldoj, Nader
    Snellings, Joachim
    Reiter, Rolf
    Lenk, Julian
    Koehlitz, Torsten
    Haas, Matthias
    Guo, Jing
    Hamm, Bernd
    Braun, Juergen
    Sack, Ingolf
    INVESTIGATIVE RADIOLOGY, 2020, 55 (08) : 524 - 530
  • [35] Prostatic inflammation is associated with benign prostatic hyperplasia rather than prostate cancer
    Falagario, U.
    Selvaggio, O.
    Carrieri, G.
    Barret, E.
    Sanguedolce, F.
    Cormio, L.
    JOURNAL OF GERONTOLOGY AND GERIATRICS, 2018, 66 (04): : 178 - 182
  • [36] Expression and significance of microRNA-205 in prostate cancer and benign prostatic hyperplasia
    Guo, Xiaogang
    Wang, Feng
    Liu, Ying
    Gao, Xingqiang
    Zhang, Min
    Liu, Qianhong
    Lin, Jing
    Li, Jingjing
    Han, Tao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (08): : 10739 - 10746
  • [37] Men's theories about benign prostatic hyperplasia and prostate cancer following a benign prostatic hyperplasia decision aid
    Holmes-Rovner, M
    Price, C
    Rovner, DR
    Kelly-Bloke, K
    Lillie, J
    Wills, C
    Bonham, VL
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 (01) : 56 - 60
  • [38] Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness
    Costantini, M.
    Belli, P.
    Rinaldi, P.
    Bufi, E.
    Giardina, G.
    Franceschini, G.
    Petrone, G.
    Bonomo, L.
    CLINICAL RADIOLOGY, 2010, 65 (12) : 1005 - 1012
  • [39] Progesterone receptor in the prostate: A potential suppressor for benign prostatic hyperplasia and prostate cancer
    Chen, RuiQi
    Yu, Yue
    Dong, Xuesen
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2017, 166 : 91 - 96
  • [40] Comparison Between Gleason Score and Apparent Diffusion Coefficient Obtained from Diffusion-Weighted Imaging of Prostate Cancer Patients
    Caivano, Rocchina
    Rabasco, Paola
    Lotumolo, Antonella
    Cirillo, Patrizia
    D'Antuono, Felice
    Zandolino, Alexis
    Villonio, Antonio
    Macarini, Luca
    Salvatore, Marco
    Cammarota, Aldo
    CANCER INVESTIGATION, 2013, 31 (09) : 625 - 629